MedPath

Polyethylene Glycol 3350

Polyethylene Glycol 3350 NF Polyethylene Glycol 3350 Powder for Oral Solution

Approved
Approval ID

a71759de-123d-4984-93e6-35661ad7d739

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 10, 2011

Manufacturers
FDA

Nexgen Pharma, Inc.

DUNS: 048488621

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Polyethylene Glycol 3350

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0722-6920
Application NumberANDA077706
Product Classification
M
Marketing Category
C73584
G
Generic Name
Polyethylene Glycol 3350
Product Specifications
Route of AdministrationORAL
Effective DateAugust 10, 2011
FDA Product Classification

INGREDIENTS (1)

POLYETHYLENE GLYCOL 3350Active
Quantity: 17 g in 1 1
Code: G2M7P15E5P
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Polyethylene Glycol 3350 - FDA Drug Approval Details